Comparative inhibitory effects of cilostazol and ticlopidine on subacute stent thrombosis and platelet function in acute myocardial infarction patients with percutaneous coronary intervention

International Heart Journal

Volumn 46, Issue 1, 2005, Pages 13-22

  Kawata, Masahito ^a   Kuramoto, Emi ^a   Kataoka, Toshio ^a   Saito, Atsushi ^a   Adachi, Kazumasa ^a   Matsuura, Akira ^a   Sakamoto, Susumu ^a  

^a AKASHI MEDICAL CENTER   (Japan)

Author keywords

Acute coronary syndrome; Antiplatelet; PCI; Platelet aggregation; Stenting

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CILOSTAZOL; HEPARIN; TICLOPIDINE; ANTITHROMBOCYTIC AGENT; TETRAZOLE DERIVATIVE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ERUPTION; DRUG MECHANISM; FEMALE; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; TACHYCARDIA; THORAX PAIN; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOSIS; DRUG COMBINATION; DRUG EFFECT; HEART INFARCTION; RETROSPECTIVE STUDY; STENT;

AGED; ASPIRIN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STENTS; TETRAZOLES; THROMBOSIS; TICLOPIDINE;

EID: 18944404742     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.46.13     Document Type: Article

References (23)

1. Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 1997; 29: 6-12.
2. Lablanche JM, McFadden EP, Bonnet JL, et al. Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. Eur Heart J 1996; 17: 1373-80.
3. Park SW, Lee CW, Kim HS, et al. Comparison of cilostazol versus ticlopidine therapy after stent implantation. Am J Cardiol 1999; 84: 511-4.
4. Yoon Y, Shim WH, Lee DH, et al. Usefulness of cilostazol versus ticlopidine in coronary artery stenting. Am J Cardiol 1999; 84: 1375-80.
5. Kamishirado H, Inoue T, Mizoguchi K, et al. Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis. Am Heart J 2002; 144: 303-8.
6. Tsui PT, Lai ST, Leung WS, et al. Prolonged jaundice following percutaneous coronary intervention and ticlopidine therapy. Hong Kong Med J 2002; 8: 57-9.
7. Kupfer Y, Tessler S. Ticlopidine and thrombotic thrombocytopenic purpura. N Engl J Med 1997; 337: 1245.
8. Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S. Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 1994; 218: 284-94.
9. Kawata M, Adachi K, Matsuura A, Sakamoto S. Comparative inhibitory effect of a two-week short-term administration of ticlopidine and a one-month administration of cilostazol on subacute stent thrombosis. Jpn J Interv Cardiol 2004; 19: 250-5.
10. Sekiguchi M, Hoshizaki H, Adachi H, Ohshima S, Taniguchi K, Kurabayashi M. Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting: a randomized comparison of ticlopidine and cilostazol. Circ J 2004; 68: 610-4.
11. Chirkov YY, Holmes AS, Willoughby SR, et al. Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets. J Am Coll Cardiol 2001; 37: 1851-7.
12. Schatz RA, Goldberg S, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent. J Am Coll Cardiol 1991; 17: 155B-9.
13. Haude M, Erbel R, Straub U, Dietz U, Meyer J. Short and long term results after intracoronary stenting in human coronary arteries: monocentre experience with the balloon-expandable Palmaz-Schatz stent. Br Heart J 1991; 66: 337-45.
14. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-88.
15. Marzocchi A, Piovaccari G, Marrozzini C, et al. Antithrombotic therapy after coronary stent placement. Cardiologia 1998; 43: 717-23.
16. Sayin T, Berkalp B, Akyurek O, Kervancioglu C, Oral D. Angiographic and clinical follow-up after coronary implantation of the ACS Multilink Duet stent: a single center experience. Jpn Heart J 2001; 42: 409-16.
17. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-23.
18. Saito S, Hosokawa FG, Kim K, Tanaka S, Miyake S. Primary stent implantation without coumadin in acute myocardial infarction. J Am Coll Cardiol 1996; 28: 74-81.
19. Moussa I, Di Mario C, Di Francesco L, Reimers B, Blengino S, Colombo A. Subacute stent thrombosis and the anticoagulation controversy: changes in drug therapy, operator technique, and the impact of intravascular ultrasound. Am J Cardiol 1996; 78: 13-7. (Review)
20. Park SJ, Shim WH, Ho DS, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003; 348: 1537-45.
21. Eto K, Takeshita S, Ochiai M, Ozaki Y, Sato T, Isshiki T. Platelet aggregation in acute coronary syndromes: use of a new aggregometer with laser light scattering to assess platelet aggregability. Cardiovasc Res 1998; 40: 223-9.
22. Tohgi H, Takahashi H, Watanabe K, Kuki H, Shirasawa Y. Development of large platelet aggregates from small aggregates as determined by laser-light scattering: effects of aggregant concentration and antiplatelet medication. Thromb Haemost 1996; 75: 838-43.
23. Saltiel E, Ward A. Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states. Drugs 1987; 34: 222-62. (Review)